Bud Selig issues his official statement on the Biogenesis suspensions

68 Comments

If there was ever a time for this pic, it’s now.

source: Reuters

Bud’s official statement:

“Major League Baseball has worked diligently with the Players Association for more than a decade to make our Joint Drug Program the best in all of professional sports.  I am proud of the comprehensive nature of our efforts – not only with regard to random testing, groundbreaking blood testing for human Growth Hormone and one of the most significant longitudinal profiling programs in the world, but also our investigative capabilities, which proved vital to the Biogenesis case.  Upon learning that players were linked to the use of performance-enhancing drugs, we vigorously pursued evidence that linked those individuals to violations of our Program.  We conducted a thorough, aggressive investigation guided by facts so that we could justly enforce our rules.

“Despite the challenges this situation has created during a great season on the field, we pursued this matter because it was not only the right thing to do, but the only thing to do.  For weeks, I have noted the many players throughout the game who have strongly voiced their support on this issue, and I thank them for it.  I appreciate the unwavering support of our owners and club personnel, who share my ardent desire to address this situation appropriately.  I am also grateful to the Professional Baseball Athletic Trainers Society and our club physicians, who were instrumental in the banning of amphetamines and whose expertise remains invaluable to me.  As an institution, we have made unprecedented strides together.

“It is important to point out that 16,000 total urine and blood tests were conducted on players worldwide under MLB Drug Programs in 2012.  With the important additions of the hGH testing and longitudinal profiling this season, we are more confident than ever in the effectiveness of the testing program.  Those players who have violated the Program have created scrutiny for the vast majority of our players, who play the game the right way.

“This case resoundingly illustrates that the strength of our Program is not limited only to testing.  We continue to attack this issue on every front – from science and research, to education and awareness, to fact-finding and investigative skills.  Major League Baseball is proud of the enormous progress we have made, and we look forward to working with the players to make the penalties for violations of the Drug Program even more stringent and a stronger deterrent.

“As a social institution with enormous social responsibilities, Baseball must do everything it can to maintain integrity, fairness and a level playing field.  We are committed to working together with players to reiterate that performance-enhancing drugs will not be tolerated in our game.”

Royals sign Drew Storen to minor league deal

Drew Storen
Getty Images
Leave a comment

The Royals are in agreement with right-handed reliever Drew Storen on a minor league deal, the team announced Friday. Per Jon Heyman of MLB Network, the deal is worth $1.25 million if the veteran righty breaks camp with the club this spring. Additional, albeit unspecified incentives will be included in the contract as well.

Storen, 31, is coming off of a protracted absence from any MLB duties. After inking a one-year deal with the Reds in 2017, he sustained a right elbow sprain toward the end of the year and underwent Tommy John surgery that October. He was effectively decommissioned for the club’s entire 2018 run and generated little interest around the league this winter, perhaps due in part to the uninspired 4.45 ERA, 3.8 BB/9, 7.9 SO/9, and career-low -0.2 fWAR he posted across 54 2/3 innings during his last healthy season.

While it’s not immediately clear what kind of performance the Royals can expect from Storen in spring training, they’re not exactly in a position to be choosy. Their bullpen ranked dead last among all MLB teams with a collective 5.04 ERA, 4.85 FIP, and -2.2 fWAR last year, and still appears to be in a state of flux as they approach Opening Day. Skipper Ned Yost told reporters Wednesday that he intends to eschew the traditional closer appointment in 2019 and will instead utilize a combination of right-handers Wily Peralta and Brad Boxberger, lefty Tim Hill, and various others as he tackles high-leverage situations in the future.